Video Experimental Relacionado

Updated: May 5, 2026

Assessing Autophagic Flux by Measuring LC3, p62, and LAMP1 Co-localization Using Multispectral Imaging Flow Cytometry

Assessing Autophagic Flux by Measuring LC3, p62, and LAMP1 Co-localization Using Multispectral Imaging Flow Cytometry

Published on: July 21, 2017

Inducción de la autofagia como un avance terapéutico para la EHGNA: evidencia actual y perspectivas

Yanke Liu¹, Mingkang Zhang², Yazhi Wang³

¹Department of Laboratory Medicine, The First Hospital of Lanzhou University, Lanzhou University, Lanzhou 730000, China.

|September 4, 2025

Resumen

La enfermedad hepática grasa no alcohólica (EHGNA) está relacionada con el deterioro de la autofagia. La restauración de este proceso celular es prometedora para el tratamiento de la EHGNA, con investigaciones en curso sobre varias intervenciones terapéuticas.

Área de la Ciencia:

Biología celular
Hepatología
La medicina molecular

Sus antecedentes:

La enfermedad hepática grasa no alcohólica (NAFLD, por sus siglas en inglés) es un problema de salud mundial frecuente que causa disfunción hepática.
Los mecanismos exactos que impulsan la progresión de la NAFLD no se comprenden completamente.
La autofagia, un proceso de reciclaje celular, está cada vez más implicada en la patogénesis de la EHGNA.

Objetivo del estudio:

Revisar la intrincada relación entre la autofagia y la EHGNA.
Explorar estrategias terapéuticas actuales y emergentes dirigidas a la autofagia para el tratamiento de la EHGNA.
Identificar objetivos moleculares potenciales para nuevos tratamientos de la ENAFLD.

Principales métodos:

Revisión exhaustiva de la literatura de los estudios que investigan la autofagia en la EHGNA.
Análisis de la investigación sobre diversas intervenciones, incluidos el estilo de vida, la farmacología y otros enfoques novedosos.
Discusión de los mecanismos moleculares y los objetivos terapéuticos potenciales.

Principales resultados:

La evidencia vincula fuertemente el deterioro de la autofagia con el desarrollo y la progresión de la NAFLD.
La restauración de la función autofágica es una estrategia potencial para mitigar la lesión hepática.
Se están explorando diversas intervenciones, desde la dieta hasta los compuestos derivados de plantas, para modular la autofagia en la EHGNA.

Conclusiones:

La autofagia juega un papel central en la fisiopatología de la EHGNA.
Dirigirse a la autofagia presenta una vía prometedora para el tratamiento de la ENAFL, aunque siguen existiendo desafíos.
La investigación adicional sobre objetivos moleculares relacionados con la autofagia es crucial para desarrollar terapias efectivas para la EHGNA.

Palabras clave:

La autofagia Dieta y ejercicio enfermedad hepática grasa no alcohólica Tratamientos farmacológicos

Más Videos Relacionados

Investigating the Protective Effects of Platycodin D on Non-Alcoholic Fatty Liver Disease in a Palmitic Acid-Induced In Vitro Model

Investigating the Protective Effects of Platycodin D on Non-Alcoholic Fatty Liver Disease in a Palmitic Acid-Induced In Vitro Model

Published on: December 2, 2022

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy

Published on: January 31, 2025

Videos de Conceptos Relacionados

Delivery Pathways to the Lysosome

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...

Autophagy

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...

Lysosomal Hydrolases

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...

NF-κB-dependent Signaling Pathway

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...

Autophagic Cell Death

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...